Basis: Latest reported fiscal quarter. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the quick ratio (acid-test) high or low?
The quick ratio (acid-test) of 7.38 is 571% above its 4-year average of 1.10, near the high end of its 4-year range (0.00–8.56).
As of the fiscal period ended Tuesday, March 31, 2026. 69.10% above its 12-month average of 4.37.
Reported quarterly quick ratio; no daily interpolation. Q3 FY2026 (2026-03-31): 7.38.
QUICK RATIO (ACID-TEST)
7.38
QUICK RATIO (ACID-TEST) AVG TTM
4.37
QUICK RATIO (ACID-TEST) AVG 3Y
1.25
QUICK RATIO (ACID-TEST) AVG 5Y
N/A
QUICK RATIO (ACID-TEST) AVG 10Y
N/A
QUICK RATIO (ACID-TEST) AVG 15Y
N/A
QUICK RATIO (ACID-TEST) AVG 20Y
N/A
CURRENT VS TTM AVG
+69.10%
CURRENT VS 3Y AVG
+491.72%
CURRENT VS 5Y AVG
N/A
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
2.79
median of 391 covered companies
CURRENT VS SECTOR MEDIAN
+164.64%
vs the sector median at left
Advanced Biomed Inc. Common Stock
Market Cap
$8.76M
Quick Ratio (Acid-Test)
7.38
TTM Avg
4.37
3Y Avg
1.25
5Y Avg
N/A
Market Cap
$8.37M
Quick Ratio (Acid-Test)
13.55
TTM Avg
6.32
3Y Avg
6.80
5Y Avg
6.83
Market Cap
$7.75M
Quick Ratio (Acid-Test)
5.86
TTM Avg
2.71
3Y Avg
2.06
5Y Avg
3.31
Market Cap
$10.27M
Quick Ratio (Acid-Test)
4.93
TTM Avg
13.09
3Y Avg
13.09
5Y Avg
13.09
Market Cap
$7.03M
Quick Ratio (Acid-Test)
45.95
TTM Avg
58.73
3Y Avg
40.89
5Y Avg
40.89
Market Cap
$6.88M
Quick Ratio (Acid-Test)
1.52
TTM Avg
3.93
3Y Avg
10.24
5Y Avg
10.80
Market Cap
$10.74M
Quick Ratio (Acid-Test)
1.37
TTM Avg
0.79
3Y Avg
1.08
5Y Avg
1.46
Market Cap
$6.76M
Quick Ratio (Acid-Test)
10.21
TTM Avg
3.61
3Y Avg
3.34
5Y Avg
4.20
| NAME | MARKET CAP | QUICK RATIO (ACID-TEST) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Advanced Biomed Inc. Common Stock (ADVB) | $8.76M | 7.38 | 4.37 | 1.25 | N/A |
| Aprea Therapeutics, Inc. (APRE)vs › | $8.37M | 13.55 | 6.32 | 6.80 | 6.83 |
| CNS Pharmaceuticals, Inc. (CNSP)vs › | $7.75M | 5.86 | 2.71 | 2.06 | 3.31 |
| Ainos, Inc. (AIMD)vs › | $9.79M | 0.12 | 0.92 | 1.12 | 0.77 |
| Caring Brands, Inc. (CABR)vs › | $10.27M | 4.93 | 13.09 | 13.09 | 13.09 |
| Curanex Pharmaceuticals Inc Common Stock (CURX)vs › | $7.03M | 45.95 | 58.73 | 40.89 | 40.89 |
| Co-Diagnostics, Inc. (CODX)vs › | $6.88M | 1.52 | 3.93 | 10.24 | 10.80 |
| Cerenome, Inc. (CNSY)vs › | $10.74M | 1.37 | 0.79 | 1.08 | 1.46 |
| Enveric Biosciences, Inc. (ENVB)vs › | $6.76M | 10.21 | 3.61 | 3.34 | 4.20 |
| Aclarion, Inc. (ACON)vs › | $6.74M | 16.20 | 7.76 | 4.60 | 3.08 |
Quick Ratio
7.38
Excludes inventory
Current Ratio
7.38
Includes inventory
Quick Ratio = (Current Assets − Inventory) / Current Liabilities
The quick ratio is a stricter liquidity measure that excludes inventory, showing the ability to meet short-term obligations with the most liquid assets.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | QUICK RATIO (ACID-TEST) |
|---|---|
| 2026-03-31 | 7.38 |
| 2025-12-31 | 8.56 |
| 2025-09-30 | 1.92 |
| 2025-06-30 | 2.09 |
| 2025-03-31 | 1.88 |
| 2024-12-31 | 0.82 |
| 2024-09-30 | 0.95 |
| 2024-06-30 | 1.12 |
| 2024-03-31 | 1.12 |
| 2023-12-31 | 0.70 |
| 2023-09-30 | 0.76 |
| 2023-06-30 | 0.85 |
| 2023-03-31 | 1.52 |
| 2022-12-31 | 0.00 |
| 2022-09-30 | 0.00 |
| 2022-06-30 | 1.67 |
